2020, Number S1
Next >>
Med Int Mex 2020; 36 (S1)
Transtorno de personalidade borderline: a duloxetina é uma estratégia eficaz e tolerável?
Shiozawa P
Language: Portugués
References: 6
Page: 1-2
PDF size: 278.99 Kb.
Text Extraction
No abstract.
REFERENCES
Drapeau M, Perry JC, Korner A. Interpersonal patterns in borderline personality disorder. J Pers Disord. 2012;26(4):583-92.
Samuels J, Eaton WW, Bienvenu OJ 3rd, Brown CH, Costa PT Jr, Nestadt G. Prevalence and correlates of personality disorders in a community sample. Br J Psychiatry. 2002;180:536-42.
Grant BF, Hasin DS, Stinson FS, Dawson DA, Chou SP, Ruan WJ, Pickering RP. Prevalence, correlates, and disability of personality disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry. 2004;65(7):948-58.
Paris J. Borderline personality disorder. CMAJ. 2005;172(12):1579-83.
Bellino S, Rinaldi C, Bozzatello P, Bogetto F. Pharmacotherapy of borderline personality disorder: a systematic review for publication purpose. Curr Med Chem. 2011;18(22):3322-9.
Bellino S, Paradiso E, Bozzatello P, Bogetto F. Efficacy and tolerability of duloxetine in the treatment of patients with borderline personality disorder: a pilot study. J Psychopharmacol. 2010;24(3):333-9.
Full text